Em um estudo de doadores de sangue nos EUA, a combinação de soroprevalência do SARS-CoV-2 oriunda de infecção ou de vacinação atingiu 94,7%.

Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021 – JAMA

Comentário no Twitter

In this study of US blood donations, the combined seroprevalence from #SARSCoV2 infection or vaccination reached 94.7% by December 2021. https://t.co/OiHICuWDo4

— JAMA (@JAMA_current) June 13, 2022